Catalogo dei prodotti della ricerca

MARINELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 441
EU - Europa 411
AS - Asia 71
AF - Africa 8
SA - Sud America 1
Totale 932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 432
IT - Italia 219
SE - Svezia 102
IN - India 30
SG - Singapore 27
DE - Germania 21
FI - Finlandia 20
BG - Bulgaria 14
IE - Irlanda 8
TG - Togo 7
CA - Canada 6
CN - Cina 6
GB - Regno Unito 6
RO - Romania 4
IR - Iran 3
MX - Messico 3
UA - Ucraina 3
BE - Belgio 2
CZ - Repubblica Ceca 2
ES - Italia 2
FR - Francia 2
HK - Hong Kong 2
NL - Olanda 2
PH - Filippine 2
AL - Albania 1
AR - Argentina 1
CH - Svizzera 1
EE - Estonia 1
IL - Israele 1
VA - Santa Sede (Città del Vaticano) 1
ZA - Sudafrica 1
Totale 932
Salva come PNG Salva come JPEG
Città #
Rome 111
Chandler 65
Fairfield 65
Ashburn 26
Princeton 22
Helsinki 20
San Paolo di Civitate 15
New York 14
Sacramento 14
Sofia 14
Seattle 13
Wilmington 13
Woodbridge 13
Cambridge 12
Millbury 12
Houston 11
Andover 10
San Diego 10
Boston 9
Bremen 9
Lawrence 9
Ann Arbor 8
Padova 8
Lomé 7
Dublin 6
Singapore 6
Norwalk 4
Toronto 4
Turin 4
Boardman 3
Mexico City 3
Brussels 2
Bühl 2
Calvanico 2
Castelnuovo di Porto 2
Catania 2
Central 2
Florence 2
Formia 2
Genoa 2
Los Angeles 2
Magenta 2
Manchester 2
Messina 2
Misterbianco 2
Montréal 2
Munich 2
Pomezia 2
Rapolla 2
Ravenna 2
Rosora 2
Silea 2
Vallefoglia 2
Zhengzhou 2
Ancona 1
Arezzo 1
Arrecife 1
Azor 1
Barcelona 1
Beijing 1
Bentivoglio 1
Bern 1
Birmingham 1
Edinburgh 1
Ercolano 1
Fano 1
Federal 1
Frosinone 1
Fuzhou 1
Groningen 1
Guidonia Montecelio 1
Kashan 1
Leawood 1
Levallois-perret 1
Menlo Park 1
Milan 1
Montclair 1
Muizenberg 1
Naples 1
Poggio Mirteto 1
Prescot 1
Quezon City 1
Quiliano 1
Rizziconi 1
San Pedro 1
Shanghai 1
Southend 1
Tallinn 1
Tirana 1
Tivoli 1
Trumbull 1
Vigonza 1
Washington 1
Zanjan 1
Totale 626
Salva come PNG Salva come JPEG
Nome #
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 56
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy 55
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden 54
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials 50
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes 46
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 46
127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma 45
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives 45
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease 41
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors 41
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments 40
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study 38
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience 37
Nodal upstaging evaluation after robotic-assisted lobectomy for early-stage non-small cell lung cancer compared to video-assisted thoracic surgery and thoracotomy: a retrospective single center analysis 33
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 33
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial 32
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence 31
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives 28
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 28
KEAP1-NFE2L2 Mutations in NSCLC: Increased Awareness Needed. Reply to “KEAP1-NFE2L2–Mutant NSCLC and Immune Checkpoint Inhibitors: A Large Database Analysis” 25
Analysis of molecular biomarkers in resected early-stage non-small cells lung cancer: a narrative review 24
null 21
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach 21
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists 19
TRF2 and VEGF-A: An unknown relationship with prognostic impact on survival of colorectal cancer patients 18
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials 17
86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma 17
Prognostic relevance of neutrophil to lymphocyte ratio (Nlr) in luminal breast cancer: A retrospective analysis in the neoadjuvant setting 17
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives 17
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 14
56P The prognostic role of {KRAS} mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy 12
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 12
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 11
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma 10
Palliative sedation and time to death in home palliative care: retrospective analysis 8
167P Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute 7
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease 4
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 4
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC 4
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis 3
11P Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations 3
Training and telemedicine: the key to the palliative medicine specialist shortage? 2
Abstract PR010: Linking proliferation rate to the evolution of single-cell primary and metastatic tumor clones 1
Totale 1.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 9 2 7 0 1
2020/2021104 0 1 0 3 2 1 6 16 15 51 9 0
2021/2022259 12 0 3 12 51 17 7 15 16 8 72 46
2022/2023423 88 63 38 35 65 31 9 32 21 22 15 4
2023/2024265 13 27 21 32 36 60 12 26 1 37 0 0
Totale 1.070